Skip to content
August 31, 2026
  • First-in-Class Takeda, Protagonist Drug Lands FDA Approval in Rare Blood Disorder
  • AI Won’t Transform Health Systems, CEOs Will — 6 Principles to Drive the Transformation
  • Big Bucks, No Whammies: Patient Access Was Never the Finish Line
  • Hospitals Are All In on AI, but Testing and Oversight Haven’t Caught Up

Medical Article

Newsletter
Random News
Headlines
  • First-in-Class Takeda, Protagonist Drug Lands FDA Approval in Rare Blood Disorder

    2 hours ago
  • AI Won’t Transform Health Systems, CEOs Will — 6 Principles to Drive the Transformation

    7 hours ago
  • Big Bucks, No Whammies: Patient Access Was Never the Finish Line

    14 hours ago
  • Hospitals Are All In on AI, but Testing and Oversight Haven’t Caught Up

    1 day ago
  • SK Bio Broadens U.S. Prospects, Licensing Late-Stage Epilepsy Drug From Biohaven

    1 day ago
  • The Missing Piece in Lowering the Cost of Care: Predictability

    1 day ago
  • Other

A Growing Akido Calls Itself ‘First AI-Native Health System’ in U.S.

1 month ago01 mins

Company is expanding its proprietary technology, ScopeAI, across its 100 clinics, virtual care, and field medicine services in California, New York City, and Rhode Island

Read More
  • Medicine

J&J Joins Immune Reset Race, Paying $785M to Partner on Sail Bio Cell Therapy

1 month ago01 mins

Johnson & Johnson also gains an exclusive option to acquire Sail Biosciences for $2.85 billion. The deal puts J&J in the mix of pharmaceutical companies developing next-generation cell therapies for applications in autoimmune diseases. The post J&J Joins Immune Reset Race, Paying $785M to Partner on Sail Bio Cell Therapy appeared first on MedCity News.

Read More
  • Other

Risant Health Sees Leadership Transition

1 month ago01 mins

After Jaewon Ryu’s departure, Dale Maxwell, former president and CEO of Presbyterian Healthcare Services, will serve as interim CEO

Read More
  • News

Health and Health Care Experiences of Uninsured Immigrants 

1 month ago01 mins

This brief provides data on health and health care experiences of uninsured immigrant adults based on a KFF survey of immigrant adults ages 18 and older conducted in partnership with The New York Times in Fall 2025. The data provide insight into how the projected coverage losses under the 2025 reconciliation law may impact health…

Read More
  • Medicine

More Medications, Less Clarity: Strengthening Polypharmacy Support for CKD Patients

1 month ago01 mins

Interdisciplinary coordination between nephrologists, primary care providers, pharmacists, dieticians, and everyone who interacts with patients is essential to ensure patient education, improve adherence, and reduce medication errors. The post More Medications, Less Clarity: Strengthening Polypharmacy Support for CKD Patients appeared first on MedCity News.

Read More
  • Medicine

The Code Gets You Paid — The Variant Gets You Treated

1 month ago01 mins

The between a code that satisfies a payer and the information a physician needs to treat a person, is what nearly every healthcare AI tool is racing past. As we push these systems toward precision medicine and genomics, that gap stops being an annoyance and becomes a patient safety issue. The post The Code Gets…

Read More
  • Medicine

Moving Beyond Reactive Healthcare: 5 Traits of Successful Healthcare Organizations

1 month ago01 mins

[Sponsored] A new whitepaper by League highlights examples from collaborations with Baptist Health. The post Moving Beyond Reactive Healthcare: 5 Traits of Successful Healthcare Organizations appeared first on MedCity News.

Read More
  • News

KFF Health Tracking Poll: Mifepristone and the Midterms

1 month ago01 mins

Amid an ongoing FDA re-review of mifepristone, awareness of the safety and prevalence of the abortion pill remains limited. This KFF poll also finds that the voters who say abortion policy is an important issue for 2026 midterm candidates to discuss are disproportionately Democrats.

Read More
  • Articles

Medicaid Insurers’ Contracts on the Line in Tight Governor’s Race

1 month ago016 mins

One of America’s most competitive gubernatorial races could settle a heated argument over whether private insurance companies should run Medicaid. The race is in Iowa, whose Medicaid program has been plagued with controversy since 2016, when the state hired national insurance companies to manage billions of dollars’ worth of benefits. That shift was made by…

Read More
  • Articles

Abortion Drug Law in Louisiana Heightens Hemorrhage Risk for Pregnant Patients

1 month ago012 mins

Over the past decade, Louisiana hospitals began stocking specialized carts designed to treat hemorrhages, one of the most common pregnancy complications in the state. The plug-in cart can be wheeled from room to room and holds surgical tools and lifesaving medications to stem blood loss. A state law passed in 2024 forced hospitals to remove…

Read More
  • 1
  • …
  • 24
  • 25
  • 26
  • 27
  • 28
  • …
  • 780

Recent Posts

  • First-in-Class Takeda, Protagonist Drug Lands FDA Approval in Rare Blood Disorder
  • AI Won’t Transform Health Systems, CEOs Will — 6 Principles to Drive the Transformation
  • Big Bucks, No Whammies: Patient Access Was Never the Finish Line
  • Hospitals Are All In on AI, but Testing and Oversight Haven’t Caught Up
  • SK Bio Broadens U.S. Prospects, Licensing Late-Stage Epilepsy Drug From Biohaven

Recent Comments

No comments to show.

Archives

  • August 2026
  • July 2026
  • June 2026
  • May 2026
  • April 2026
  • March 2026
  • February 2026
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • April 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • October 2024
  • September 2024
  • August 2024
  • March 2024

Categories

  • Articles
  • Medicine
  • News
  • Other
Newsmatic - News WordPress Theme 2026. Powered By BlazeThemes.